This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Stocks in Motion

Nutrition 21 (NXXI) soared 62% after the company received a purchase order from Rite Aid (RAD - Get Report) for the company's Chromax chromium picolinate product. The product will be distributed to more than 3,400 Rite Aid stores and mark the first time that Nutrition 21's Chromax product will be available in retail stores. "Our direct distribution strategy is on schedule," the company said in a statement. "The Rite Aid commitment is a significant initial step in our transition from primarily a wholesale ingredients supplier to also a supplier of branded finished goods." Shares were trading up 43 cents to $1.12.

Other health care volume movers included Pfizer (PFE), down 6 cents to $24.52; Guidant (GDT), up 50 cents to $70.90; Elan (ELN), down 17 cents to $16.02; Bristol-Myers Squibb (BMY), down 16 cents to $22.30; Nektar Therapeutic (NKTR), up $1.79 to $19.90; UnitedHealth Group (UNH), down $2.12 to $60.41; Boston Scientific (BSX), up 3 cents to $25.08; Amgen (AMGN), up 55 cents to $77.75; Johnson & Johnson (JNJ), down 64 cents to $61.57; Merck (MRK), up 11 cents to $33.59; and Schering-Plough (SGP), down 22 cents to $20.11.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
HCA $69.19 0.00%
RAD $7.91 0.00%
AAPL $94.02 0.00%
FB $104.07 0.00%
GOOG $683.57 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs